Suppr超能文献

速激肽能有效刺激人体小肠血流:一项人体激光多普勒血流仪研究

Tachykinins potently stimulate human small bowel blood flow: a laser Doppler flowmetry study in humans.

作者信息

Schmidt P T, Lördal M, Gazelius B, Hellström P M

机构信息

Department of Medicine, Unit of Gastroenterology, Karolinska Hospital, Stockholm, Sweden.

出版信息

Gut. 2003 Jan;52(1):53-6. doi: 10.1136/gut.52.1.53.

Abstract

BACKGROUND

The two tachykinins substance P and neurokinin A are abundantly present in the gastrointestinal tract. Substance P preferring neurokinin 1 receptors are mainly found in submucosal blood vessels while neurokinin A preferring neurokinin 2 receptors seem to be confined to smooth muscle cells. Tachykinin effects on intestinal mucosal blood flow in humans are not known.

AIM

To study the effects of substance P and neurokinin A on small bowel mucosal blood flow in humans.

METHODS

A manometry tube supplied with single fibre microprobes recorded mucosal blood flow in the proximal small bowel using laser Doppler flowmetry, concomitant with luminal manometry, defining phases I, II, and III of the migrating motor complex. Simultaneously, flowmetry of temporal skin was performed. Under fasting conditions saline was infused intravenously over four hours followed by infusion of substance P, neurokinin A, or saline.

RESULTS

During phase I, substance 1-6 pmol/kg/min increased mucosal blood flow dose dependently by a maximum of 158%. Blood flow of the temporal skin increased in parallel. Neurokinin A 6-50 pmol/kg/min increased mucosal blood flow maximally by 86% at 25 pmol/kg/min while blood flow of temporal skin increased at all doses. Substance P at all doses and neurokinin A at the highest dose only, increased pulse rate. Systolic blood pressure was unchanged by either peptide while substance P at the highest dose decreased diastolic pressure.

CONCLUSION

Tachykinins increase blood flow of the small bowel and temporal skin. With substance P being more potent than neurokinin A, these effects are probably mediated through neurokinin 1 receptors.

摘要

背景

速激肽P物质和神经激肽A在胃肠道中大量存在。P物质主要作用于神经激肽1受体,主要存在于黏膜下血管,而神经激肽A主要作用于神经激肽2受体,似乎局限于平滑肌细胞。速激肽对人体小肠黏膜血流的影响尚不清楚。

目的

研究P物质和神经激肽A对人体小肠黏膜血流的影响。

方法

一根配备单纤维微探针的测压管,使用激光多普勒血流仪记录近端小肠的黏膜血流,同时进行腔内测压,确定移行性运动复合波的I、II和III期。同时,对颞部皮肤进行血流测定。在禁食条件下,静脉输注生理盐水4小时,随后输注P物质、神经激肽A或生理盐水。

结果

在I期,P物质以1 - 6 pmol/kg/min的剂量静脉输注时,黏膜血流呈剂量依赖性增加,最大增幅为158%。颞部皮肤血流也相应增加。神经激肽A以6 - 50 pmol/kg/min的剂量静脉输注时,在25 pmol/kg/min时黏膜血流最大增加86%,而颞部皮肤血流在所有剂量下均增加。所有剂量的P物质和仅最高剂量的神经激肽A可增加脉搏率。两种肽均未改变收缩压,而最高剂量的P物质可降低舒张压。

结论

速激肽可增加小肠和颞部皮肤的血流。由于P物质比神经激肽A更有效,这些作用可能是通过神经激肽1受体介导的。

相似文献

引用本文的文献

1
Recent Developments in On-Demand Voiding Therapies.按需排尿治疗的最新进展。
J Pharmacol Exp Ther. 2024 Aug 19;390(3):302-317. doi: 10.1124/jpet.123.002073.
4
Colorectal and cardiovascular effects of [Lys,MeLeu,Nle]-NKA in anesthetized macaques.麻醉猕猴中[Lys,MeLeu,Nle]-NKA 的结直肠和心血管作用。
Naunyn Schmiedebergs Arch Pharmacol. 2018 Sep;391(9):907-914. doi: 10.1007/s00210-018-1520-6. Epub 2018 Jun 1.

本文引用的文献

1
Management of the irritable bowel syndrome.肠易激综合征的管理
Gastroenterology. 2001 Feb;120(3):652-68. doi: 10.1053/gast.2001.21908.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验